CORRECTION OF EAR DEFORMITIES IN NEWBORNS BY MODELING, COMPARISON OF TWO PROTOCOLS (MOLDEAR)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Alexis VEYSSIERE
- Phone Number: +33 +33231063106
- Email: drci-secretariat@chu-caen.fr
Study Contact Backup
- Name: VEYSSIERE
- Email: drci-secretariat@chu-caen.fr
Study Locations
-
-
N
-
Caen, N, France, 14000
- Recruiting
- Caen University hospital
-
Contact:
- Alexis VEYSSIERE
- Phone Number: +33 +33231063106
- Email: drci-secretariat@chu-caen.fr
-
Contact:
- Alexis VEYSSIERE, MD
-
Principal Investigator:
- Alexis VEYSSIERE, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Newborn, age between 8 days and 1 month
- newborn with ear malformation
Exclusion Criteria:
- Total chondrocutaneous agenesis of the ear
- polymalformative syndrome
- age greater than 4 weeks
- parental refusal
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Control group
Correction of deformation using the adjustable Earwell device
|
Correction of deformation using the adjustable Earwell device
|
|
Experimental: Intervention group
Correction of deformation using the custom-made silicone device
|
Correction of deformation using the custom-made silicone device
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective ear deformation score
Time Frame: baseline and 1 year after
|
Evaluation of the non-inferiority of the custom-made device developed in the maxillofacial surgery department of Caen University Hospital compared to the device from the EarWell™ group.
|
baseline and 1 year after
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 21-0023 (Other Grant/Funding Number: DMID reference)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.